Safety and efficacy of risedronate for patients with esophageal varices and liver cirrhosis: a non-randomized clinical trial

Despite the high prevalence of osteoporosis in liver cirrhosis, the indication of bisphosphonates for patients with esophageal varices has been avoided due to risk of digestive mucosal damage. Therefore, this study aimed to evaluate the safety profile of risedronate treatment for patients with osteo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Talles Bazeia, Santos, Lívia Alves Amaral, Nunes, Hélio Rubens de Carvalho, Silva, Giovanni Faria, Caramori, Carlos Antonio, Qi, Xingshun, Romeiro, Fernando Gomes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908659/
https://www.ncbi.nlm.nih.gov/pubmed/31831865
http://dx.doi.org/10.1038/s41598-019-55603-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908659/
https://www.ncbi.nlm.nih.gov/pubmed/31831865
http://dx.doi.org/10.1038/s41598-019-55603-y

Ejemplares similares